The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...

The U.S. Food and Drug Administration (FDA) has approved FluMist for self-administration. On Friday, the FDA announced that ...

The FluMist vaccine, manufactured by AstraZeneca, was approved in 2003 for health care providers to give patients, but the method has gotten renewed attention due to a new, broader approval. On Friday ...

The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...

AstraZeneca has a new at-home flu vaccine coming out. When will it arrive and how will it be administered? Here's what to ...

The spray could be an alternative for people who are averse to getting injections, or otherwise find it difficult or ...

· FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider. · FluMist ...

I love being able to go to the pharmacy for my own (or my kids’) flu shots. Pop in, get the shot, then go about my day. That ...

AstraZeneca released results from the TROPION-Breast01 Phase 3 trial of datopotamab deruxtecan, showing no statistically ...

US FDA approves AstraZeneca’s needle-free nasal spray, FluMist for self-administration: Cambridge, UK Monday, September 23, 2024, 09:00 Hrs [IST] AstraZeneca, a global, science- ...

In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration.

The FDA approved FluMist, a nasal spray flu vaccine for self-administration, making it the first flu vaccine of its kind available for at home use.